BF Biosciences Limited (PSX:BFBIO)
150.37
-6.41 (-4.09%)
At close: Apr 20, 2026
BF Biosciences Market Cap
BF Biosciences has a market cap or net worth of 13.28 billion as of April 21, 2026. Its market cap has decreased by -2.15% in one year.
Market Cap
13.28B
Enterprise Value
13.02B
Revenue
8.22B
Ranking
n/a
PE Ratio
22.17
Stock Price
150.37
Market Cap Chart
Since October 22, 2024, BF Biosciences's market cap has increased from 7.41B to 13.28B, an increase of 79.32%. That is a compound annual growth rate of 47.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 13.28B | 7.01% |
| Dec 31, 2025 | 12.41B | -40.17% |
| Dec 31, 2024 | 20.75B | 180.05% |
| Oct 22, 2024 | 7.41B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fast Cables | 14.30B |
| Jubilee General Insurance Company | 14.09B |
| Macter International | 14.03B |
| MCB investment management | 13.76B |
| Avanceon | 13.73B |
| Unity Foods | 13.61B |
| Archroma Pakistan | 13.55B |
| Khairpur Sugar Mills | 13.49B |